Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BX vs MRNA✓SelectedUSD · MRNABX vs MRNA performance historyLatest closeAs of+0.24%11/19
Stock and ETF performance explorer

BX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+394.1%
MRNA return
+806.0%
Excess return
-411.9%
Maximum drawdown
-49.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.2%+1.3%-1.0%+0.2%
7D-2.2%-13.8%+11.7%-1.2%
30D+6.1%-17.7%+23.8%+7.2%
3M-19.3%+14.3%-33.6%-20.7%
6M+3.5%+336.0%-332.5%-13.3%
YTD-21.6%+575.9%-597.6%-37.7%
1Y-12.9%+724.4%-737.3%-32.3%
3Y+21.7%+160.8%-139.1%+2.1%
5Y-5.5%-24.4%+18.9%-16.2%
All+394.1%+806.0%-411.9%+319.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling